1.
Clin Case Rep
; 9(1): 594-596, 2021 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33489227
RESUMO
Although paclitaxel is known to cause mild skin toxicity, it may induce severe HFS requiring drug withdrawal. Patients with high disease burden might receive prolonged paclitaxel chemotherapy. Hence, a grade 2 toxicity would better indicate withdrawal of paclitaxel instead of suspension and rechallenge, to prevent such severe HFS requiring long-time recovery.